It has been reported that mutations in NaV1.5 and in the NaV1.5-interacting genes that modify its function and trafficking cause arrhythmic syndromes and cardiomyopathies with contractile dysfunction (see References [23] and references therein). This evidence concerns the gene SCN5A and cardiomyopathy.